Abstract
Background: Insulin degludec is a novel ultra-long-acting basal insulin, which is used clinically first in Japan. We aimed to study efficacy of insulin degludec compared with insulin glargine in pa-tients with type 1 diabetes, by using continuous glucose monitoring (CGM).
Cite
CITATION STYLE
APA
Hamasaki. (2013). Comparison of Glycemic Variability by Using Insulin Glargine and Insulin Degludec in Japanese Patients With Type 1 Diabetes, Monitored by Continuous Glucose Monitoring: A Preliminary Report. Journal of Endocrinology and Metabolism. https://doi.org/10.4021/jem193w
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free